Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24178
Title: | The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review | Authors: | MESSIAEN, Peter Cuyx, Senne DEJAGERE, Tom VAN DER HILST, Jeroen |
Issue Date: | 2017 | Publisher: | WILEY | Source: | TRANSPLANT INFECTIOUS DISEASE, 19(2), p. 1-6 (Art N° e12651) | Abstract: | Background: In recent years, the incidence of Pneumocystis jirovecii pneumonia (PJP) has increased in immunocompromised patients without human immunodeficiency virus (HIV) infection. Chemoprophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) is highly effective in preventing PJP in both HIV-positive and -seronegative patients. In HIV-positive patients, the risk of PJP is strongly correlated with decreased CD4 cell count. The role of CD4 cell count in the pathogenesis of PJP in non-HIV immunocompromised patients is less well studied. For most immunosuppressive conditions, no clear guidelines indicate whether to start TMP-SMX. Method: We conducted a systematic literature review with the aim to provide a comprehensive overview on the role of CD4 cell counts in managing the risk of PJP in HIV-seronegative patients. Results: Of the 63 individual studies retrieved, 14 studies report on CD4 cell counts in a variety of immunosuppressive conditions. CD4 cell count were < 200/mu L in 73.1% of the patients. Conclusion: CD4 cell count < 200/mu L is a sensitive biomarker to identify non-HIV immunocompromised patients who are at risk for PJP. Measuring CD4 cell counts could help clinicians identify patients who may benefit from TMP-SMX prophylaxis. | Notes: | [Messiaen, Peter E.; Cuyx, Senne; van der Hilst, Jeroen C.] Jessa Hosp, Dept Infect Dis & Immun, Hasselt, Belgium. [Messiaen, Peter E.; van der Hilst, Jeroen C.] Hasselt Univ, Biomed Res Inst BIOMED, Hasselt, Belgium. [Dejagere, Tom] Jessa Hosp, Dept Nephrol, Hasselt, Belgium. | Keywords: | CD4 cell count; non-HIV; PJP; Pneumocystis; TMP-SMX;CD4 cell count; non-HIV; PJP; Pneumocystis; TMP-SMX | Document URI: | http://hdl.handle.net/1942/24178 | ISSN: | 1398-2273 | e-ISSN: | 1399-3062 | DOI: | 10.1111/tid.12651 | ISI #: | 000398574400001 | Rights: | (c) 2017 John Wiley & Sons A/S | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2018 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Messiaen_et_al-2017-Transplant_Infectious_Disease.pdf Restricted Access | Published version | 322.32 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.